HIGHLIGHTS
- who: Report et al. from the (UNIVERSITY) have published the article: Review began 07/27/2022 Review ended 08/22/2022 Published 08/25/2022 © Copyright, in the Journal: (JOURNAL) of August/25,/2022
- what: The aim of this case is to highlight the ocular complications of dabrafenib and trametinib treatment.
- future: The immunotherapy-first approach is expected to play an important role in the near future unless metastatic BRAF-mutated melanoma presents in visceral crises .
SUMMARY
The incidence of melanoma has been on the rise in recent years . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.